Home

Intelligence

Services

Subscriptions

News

About Us

Sign In

 

Document Preview

Guaranteed Convertible Notes

 

Click "Add to Cart" button to purchase document. 
Documents are emailed immediately after purchase. 
You can also browse documents by
title, category, or company... or click here for help finding documents.

 

Title:

Guaranteed Convertible Notes

Entities:

aaiPharma Inc.; Acusphere, Inc.; Allergan, Inc.; Amarin Corp. plc; Anesta Corp.; Antigenics, Inc.; Atrix Laboratories, Inc.; Bank of Ireland; Biogen, Inc.; Bristol-Myers Squibb Co.; Cardinal Health, Inc.; Elan Corp., plc; Elite Pharmaceuticals, Inc.; Enzon Pharmaceuticals, Inc.; Eon Labs, Inc.; Generex Biotechnology Corp.; GlaxoSmithKline plc; GlycoGenesys, Inc.; IVAX Corp.; Ligand Pharmaceuticals, Inc.; McKesson Corp.; Novartis AG; Pfizer, Inc.; Schwarz Pharma, Inc.; Women First HealthCare Inc.; Wyeth; Bank of New York; Kirkpatrick & Lockhart; Shearman & Sterling

Date:

2003

Size:

Preview shows 7KB of 24KB total

Price:

$39

ID:

#162550

 

 

► Miscellany ► Documents ► Misc. Documents
► Miscellany ► Fortune 100
► Financial ► Money Center Banks
► Financial ► Regional Banks
► Biotechnology & Drugs
► Miscellany
► Services ► Legal
► Miscellany ► Watch List
► Biotech & Drugs ► Pharmaceutical Preparations
► Biotech & Drugs ► Biological Products

 

 

Start of Preview


                            ELAN CAPITAL CORP., LTD.

(incorporated with limited liability under the laws of
Bermuda with registered number 34207)

US$460,000,000
6.50% GUARANTEED CONVERTIBLE NOTES DUE 2008

----------

fully and unconditionally guaranteed by, and convertible into
Ordinary Shares of,
ELAN CORPORATION, PLC
(incorporated with limited liability under the laws of Ireland
with registered number 30356)

Interest on the Notes is payable semi-annually in arrears on 10 May and 10
November in each year commencing on 10 May 2004.

THE US$460,000,000 AGGREGATE PRINCIPAL AMOUNT 6.50% GUARANTEED CONVERTIBLE
NOTES DUE 2008 (THE "NOTES") ARE PROPOSED TO BE ISSUED ON 10 NOVEMBER 2003 (THE
DATE THE NOTES ARE ISSUED, THE "ISSUE DATE") BY ELAN CAPITAL CORP., LTD. ("ELAN
CAPITAL" OR THE "ISSUER"). ELAN CORPORATION, PLC ("ELAN", THE "GUARANTOR" OR THE
"COMPANY") WILL FULLY AND UNCONDITIONALLY GUARANTEE THE NOTES (THE "GUARANTEE").
THE GUARANTEE WILL BE SUBORDINATED ON THE BASIS DESCRIBED UNDER "DESCRIPTION OF
GUARANTEED CONVERTIBLE NOTES OF ELAN CAPITAL AND GUARANTEE OF ELAN". THE NOTES
WILL MATURE ON 10 NOVEMBER 2008 (THE "MATURITY DATE"). HOLDERS MAY CONVERT EACH
US$1,000 IN PRINCIPAL AMOUNT OF THE NOTES INTO 134.7709 AMERICAN DEPOSITARY
SHARES ("ADSS", EACH ADS REPRESENTING ONE FULLY PAID ORDINARY SHARE, EVIDENCED
BY ONE AMERICAN DEPOSITARY RECEIPT) OR 134.7709 FULLY PAID ORDINARY SHARES (EACH
AN "ORDINARY SHARE"), OF ELAN, PAR VALUE Euro 0.05 EACH (THE ORDINARY SHARES AND
THE ADSS ARE COLLECTIVELY REFERRED TO IN THIS OFFERING CIRCULAR AS THE
"SHARES").

UNDER CERTAIN CIRCUMSTANCES, ELAN CAPITAL MAY REDEEM THE NOTES, IN WHOLE OR
IN PART, AT ANY TIME AFTER 1 DECEMBER 2006, AT A REDEMPTION PRICE EQUAL TO 100%
OF THE PRINCIPAL AMOUNT PLUS ACCRUED AND UNPAID INTEREST TO, BUT EXCLUDING, THE
REDEMPTION DATE. UNLESS PREVIOUSLY REDEEMED OR REPURCHASED, EACH NOTE WILL,
SUBJECT TO CERTAIN CONDITIONS DESCRIBED HEREIN, BE CONVERTIBLE AT THE OPTION OF
THE HOLDER (THE "NOTEHOLDER") AT ANY TIME BEGINNING ONE HUNDRED AND TWENTY (120)
DAYS AFTER THE ISSUE DATE AND UNTIL THE CLOSE OF BUSINESS ON THE SEVENTH
BUSINESS DAY PRIOR TO THE MATURITY DATE. IN THE CASE OF NOTES CALLED FOR
REDEMPTION, THE NOTEHOLDER'S CONVERSION RIGHTS WILL EXPIRE AT THE CLOSE OF
BUSINESS ON THE SEVENTH BUSINESS DAY PRECEDING THE DATE FIXED FOR REDEMPTION.
UNLESS PREVIOUSLY REDEEMED, CONVERTED OR PURCHASED AND CANCELLED, THE NOTES WILL
BE REDEEMED AT THEIR PRINCIPAL AMOUNT TOGETHER WITH UNPAID ACCRUED INTEREST ON
THE MATURITY DATE. FOR A MORE DETAILED DESCRIPTION OF THE NOTES SEE "DESCRIPTION
OF THE GUARANTEED CONVERTIBLE NOTES OF ELAN CAPITAL AND GUARANTEE OF ELAN".

APPLICATION HAS BEEN MADE TO THE FINANCIAL SERVICES AUTHORITY IN ITS
CAPACITY AS COMPETENT AUTHORITY UNDER THE FINANCIAL SERVICES AND MARKETS ACT
2000 (THE "FSMA"), (THE "UK LISTING AUTHORITY") FOR THE NOTES TO BE ADMITTED TO
THE OFFICIAL LIST OF THE UK LISTING AUTHORITY (THE "OFFICIAL LIST") AND TO THE
LONDON STOCK EXCHANGE PLC (THE "LONDON STOCK EXCHANGE") FOR SUCH NOTES TO BE
ADMITTED TO TRADING ON THE LONDON STOCK EXCHANGE'S MARKET FOR LISTED SECURITIES.
ADMISSION TO THE OFFICIAL LIST OF THE UK LISTING AUTHORITY TOGETHER WITH
ADMISSION TO TRADING ON THE LONDON STOCK EXCHANGE'S MARKET FOR LISTED SECURITIES
CONSTITUTE OFFICIAL LISTING ON A STOCK EXCHANGE. THE ADMISSION TO THE OFFICIAL
LIST IS EXPECTED TO TAKE PLACE ON 11 NOVEMBER 2003. A COPY OF THIS OFFERING
CIRCULAR INCLUDING ANNEX A AND ANNEX B, WHICH TOGETHER COMPRISE LISTING
PARTICULARS, HAS BEEN DELIVERED TO THE REGISTRAR OF COMPANIES IN ENGLAND AND
WALES AS REQUIRED BY SECTION 83 OF THE FSMA.

APPLICATION HAS BEEN MADE TO THE IRISH STOCK EXCHANGE FOR THE NOTES TO BE
ADMITTED TO THE OFFICIAL LIST OF THE IRISH STOCK EXCHANGE (THE "ISE OFFICIAL
LIST"). ADMISSION TO THE ISE OFFICIAL LIST IS EXPECTED TO TAKE PLACE ON 11
NOVEMBER, 2003. A COPY OF THIS OFFERING CIRCULAR INCLUDING ANNEX A AND ANNEX B,
WHICH TOGETHER COMPRISE LISTING PARTICULARS APPROVED BY THE IRISH STOCK
EXCHANGE, HAS BEEN DELIVERED TO THE REGISTRAR OF COMPANIES IN IRELAND FOR
REGISTRATION AS REQUIRED BY THE EUROPEAN COMMUNITIES (STOCK EXCHANGE)
REGULATIONS 1984 OF IRELAND (AS AMENDED) (THE "1984 REGULATIONS").

INVESTING IN THE NOTES INVOLVES RISK. SEE "RISK FACTORS" BEGINNING ON PAGE 43.

PRICE 100%

THE NOTES, THE GUARANTEE AND THE ORDINARY SHARES HAVE NOT BEEN, AND WILL
NOT BE, REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE
"SECURITIES ACT"), AND ARE SUBJECT TO US TAX LAW REQUIREMENTS. THE NOTES ARE
BEING OFFERED OUTSIDE THE UNITED STATES BY MORGAN STANLEY & CO. INTERNATIONAL
LIMITED (THE "MANAGER") TO PERSONS OTHER THAN US PERSONS (WITHIN THE MEANING OF
REGULATION S PROMULGATED UNDER THE SECURITIES ACT ("REGULATION S")) IN
ACCORDANCE WITH REGULATION S, AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN
THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS (WITHIN
THE MEANING OF REGULATION S) EXCEPT PURSUANT TO AN EXEMPTION FROM, OR IN A
TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.
FOR A DESCRIPTION OF CERTAIN FURTHER RESTRICTIONS ON OFFERS AND SALES OF NOTES
AND DISTRIBUTION OF THIS OFFERING CIRCULAR, SEE "SUBSCRIPTION AND SALE".

THE MANAGER EXPECTS TO DELIVER THE NOTES TO PURCHASERS ON 10 NOVEMBER 2003.

MORGAN STANLEY
6 NOVEMBER 2003


{PAGE}



This Offering Circular including Annex A and Annex B together comprise
listing particulars issued in compliance with the listing rules made (i) under
section 74 of the FSMA by the UK Listing Authority (the "LISTING RULES") and
(ii) by the Irish Stock Exchange under the 1984 Regulations (the "IRISH LISTING

 

End of Preview

 

Home        Intelligence        Services        Subscriptions        News        About Us

Contact Us       Terms of Use       Resend Documents       Shopping Cart

Copyright © 2008 The Consus Group LLC